Krook JE - Search Results

1

Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.

Hobday TJ, Kugler JW, Mahoney MR, Sargent DJ, Sloan JA, Fitch TR, Krook JE, O'Connell MJ, Mailliard JA, Tirona MT, Tschetter LK, Cobau CD, Goldberg RM. Hobday TJ, et al. Among authors: krook je. J Clin Oncol. 2002 Dec 1;20(23):4574-80. doi: 10.1200/JCO.2002.08.535. J Clin Oncol. 2002. PMID: 12454115 Clinical Trial.

2

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Jatoi A, et al. Among authors: krook je. J Clin Oncol. 2002 Jan 15;20(2):567-73. doi: 10.1200/JCO.2002.20.2.567. J Clin Oncol. 2002. PMID: 11786587 Clinical Trial.

3

Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program.

Goldberg RM, Sargent DJ, Morton RF, Mahoney MR, Krook JE, O'Connell MJ. Goldberg RM, et al. Among authors: krook je. J Clin Oncol. 2002 Dec 1;20(23):4591-6. doi: 10.1200/JCO.2002.03.039. J Clin Oncol. 2002. PMID: 12454117 Review.

4

Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanoma.

Markovic S, Suman VJ, Dalton RJ, Woods JE, Fitzgibbons RJ Jr, Wold LE, Buckner JC, Kugler JW, Mailliard JA, Rowland KM, Krook JE, Brown DW, Tirona MT, Creagan ET. Markovic S, et al. Among authors: krook je. Am J Clin Oncol. 2002 Dec;25(6):552-6. doi: 10.1097/00000421-200212000-00003. Am J Clin Oncol. 2002. PMID: 12477996 Clinical Trial.

5

Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.

Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, Kardinal CG, Knost JA, Tirona MT, Addo F, Morton RF, Michalak JC, Schaefer PL, Porter PA, Stella PJ. Hurt RD, et al. Among authors: krook je. J Clin Oncol. 2003 Mar 1;21(5):914-20. doi: 10.1200/JCO.2003.08.160. J Clin Oncol. 2003. PMID: 12610193 Clinical Trial.

6

A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.

Marks RS, Graham DL, Sloan JA, Hillman S, Fishkoff S, Krook JE, Okuno SH, Mailliard JA, Fitch TR, Addo F. Marks RS, et al. Among authors: krook je. Am J Clin Oncol. 2003 Aug;26(4):336-7. doi: 10.1097/01.COC.0000020962.25210.6F. Am J Clin Oncol. 2003. PMID: 12902880 Clinical Trial.

7

Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.

Garrity MM, Burgart LJ, Mahoney MR, Windschitl HE, Salim M, Wiesenfeld M, Krook JE, Michalak JC, Goldberg RM, O'Connell MJ, Furth AF, Sargent DJ, Murphy LM, Hill E, Riehle DL, Meyers CH, Witzig TE; North Central Cancer Treatment Group. Garrity MM, et al. Among authors: krook je. J Clin Oncol. 2004 May 1;22(9):1572-82. doi: 10.1200/JCO.2004.10.042. J Clin Oncol. 2004. PMID: 15117979

8

Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.

Kanard A, Jatoi A, Castillo R, Geyer S, Schulz TK, Fitch TR, Rowland KM, Nair S, Krook JE, Kugler JW. Kanard A, et al. Among authors: krook je. Lung Cancer. 2004 Mar;43(3):345-53. doi: 10.1016/j.lungcan.2003.09.012. Lung Cancer. 2004. PMID: 15165094 Clinical Trial.

9

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.

Perez EA, Hillman DW, Mailliard JA, Ingle JN, Ryan JM, Fitch TR, Rowland KM, Kardinal CG, Krook JE, Kugler JW, Dakhil SR. Perez EA, et al. Among authors: krook je. J Clin Oncol. 2004 Jul 15;22(14):2849-55. doi: 10.1200/JCO.2004.10.047. J Clin Oncol. 2004. PMID: 15254052 Clinical Trial.

10

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF. Witzig TE, et al. Among authors: krook je. J Clin Oncol. 2005 Apr 20;23(12):2606-17. doi: 10.1200/JCO.2004.10.020. Epub 2004 Sep 27. J Clin Oncol. 2005. PMID: 15452187 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page